期刊文献+

肌钙蛋白T与N端脑钠肽原在慢性心衰危险预测中的应用 被引量:1

下载PDF
导出
摘要 心力衰竭(heart failure,HF)是常见的心血管疾病,3年病死率约为60%。因心力衰竭住院的患者在以后12周内因心力衰竭再住院或死亡的发生率为25%。心力衰竭所致的死亡率在我国呈逐年上升趋势,在较短时间内对心力衰竭患者作出正确的诊断十分重要。传统诊断心衰的指标主要依靠心电图、超声心动图和临床体征,一直缺乏有效评价心脏功能的实验室检测指标,生物标志物分析可能是心衰诊断的重要补充。目前几个大的、以成果为基础的研究,正着手调查使用BNP系列监测心衰病人的发病率,死亡率及整体医疗费用的降低。
作者 周春花 邓平
机构地区 南华大学医学院
出处 《中国医药导刊》 2009年第1期74-76,共3页 Chinese Journal of Medicinal Guide
  • 相关文献

参考文献16

  • 1Gallegns PJ,Maclaugldin EJ,Haase KK.Serial monitoring of brain natriuretic peptide concentrations for drug thempy management in patients with chronic heart failure.Pharmacotherapy,2008;28(3):343-355
  • 2Povar MJ,Franeo SJ,Bustamante RE.et al Utility of N-terminal pro-brain natriuretic peptide for the diagnosis of heart failure in a heterogeneous populations of dys-Pnoeic patients:a Spanish multicetre study.J Eur J Emerg Med,2006;13(1):53-54
  • 3Worster A,Balion CM,Hill SA,et al.Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea:a systematic review.Clin Biochem,2008;41(4-5):250-259
  • 4Bettencourt PM.Clinical usefulness of B-Type natriuretic poptide measurement:Present and future perspectives.J Heart,2005;91(11):1489-1494
  • 5Balion CM,McKelvie RS,Reiehert S.Monitoring the response to pharmacologic thempy in patients with stable chronic heart failure:is BNP or NT-proBNP a useful assessment tool?Clin Biochem,2008;41(4-5):266-276.
  • 6Doust JA,Pietrzak E,Dobson A,et al How well dose B-Type natriurotic peptide predict death and cardiac events in patients with heart failure:systematic review.J BMJ,2005;330(7 492):625
  • 7Logeart D,Thabut G,Jourdain P,et al.Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.J Am Coll Cardiol,2004;43:635-641
  • 8Schou M,Gustafsson F,Videbaek L,et al.Design and methodology of the NorthStar Study:NT-proBNP stratified follow-up in outpatient heart failure clinics-a randomized Danish multicenter study.Am Heart J,2008;156(4):649-655
  • 9Horwich TB,Patel J,MacLellan WR,Fonarow GC.Cardiac troponin I is associated with impaired hemodynamics,progressive left ventricular dysfunction,and increased mortality rates in advanced heart failure.Circulation,2003;108:833-838
  • 10Sate Y,Kuwabara Y,Taniguchi R,et,al.Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin.Int J Cardiol,2008;126(2):171-176

二级参考文献5

  • 1Masson S, Vago T, Baldi G, et al. Comparative measurement of Nter-minal pro- brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med,2002,40(8) :761.
  • 2Groenning BA, Nilsson JC, Sondergaanzl L, et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic pepfide concentrations. Am Heart J, 2002, 143(5):923.
  • 3Yancy CW, Saltzberg M, Berkowitz RL. For the FUSION Investigators.Management of patients with congestive heart failure after hospitalization:Restrlts from the Follow Up Serial Infusions of Nesiritide (FUSION) trial.J Card Fail,2003,9(5 Suppl) :232.
  • 4Costanzo MR, Heywood JT, Ememum CL, et al. Evaluation of in-hospital mortality in patients treated for acute heart failure with in the first 24 hours with nesiritide vs. other vasoactive or inotropic agents. Circulation,2003,108(17 Suppl IV):695.
  • 5梁红,翁渝国.心室辅助装置对改善终末期心力衰竭患者心功能的作用[J].中华心血管病杂志,2000,28(2):108-110. 被引量:7

共引文献2

同被引文献9

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部